Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-063615

Executive Vice President sold 40,000 shares at an average $30.81 ($1,232,528)

  • Executive Vice President acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Holsinger Leslie · Executive Vice President

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-14 Exercise or conversion : show line 1 in the form +40,000 $0.27 $10,800 43,500 D
2020-12-14 Sale : show line 2 in the form −1,700 $28.80 $48,960 41,800 D
2020-12-14 Sale : show line 3 in the form −14,275 $30.15 $430,391 27,525 D
2020-12-14 Sale : show line 4 in the form −13,200 $30.91 $408,012 14,325 D
2020-12-14 Sale : show line 5 in the form −9,525 $31.79 $302,800 1,800 D
2020-12-14 Sale : show line 6 in the form −400 $32.59 $13,034 4,400 D
2020-12-14 Sale : show line 7 in the form −900 $32.59 $29,331 3,500 D
Open-market sales · 40,000 sh · avg $30.81 · $1,232,528

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-12-11 Grant or award : show line 8 in the form Stock Option (Right to Buy) +100,000 100,000 D
2020-12-11 Grant or award : show line 9 in the form Stock Option (Right to Buy) +100,000 100,000 D
2020-12-14 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −40,000 66,794 D
Loading xslF345X03/doc4.xml…